Medicinal Cannabis and CBD in Mental Healthcare
Autor Kylie O'Brien, Philip Blairen Limba Engleză Paperback – 28 oct 2021
The book describes the endocannabinoid system, how stress and the endocannabinoid system interact and key constituents, pharmacokinetics and safety aspects of medicinal cannabis, focusing on CBD and THC. Chapters on specific mental health conditions describe the underpinning pathomechanisms including how the endocannabinoid system is involved, and summarises the scientific evidence including animal and human research for the use of CBD and THC in treatment of such conditions. Topics covered include anxiety, depression, post-traumatic stress disorder, insomnia, Alzheimer's Disease and autism spectrum disorder. Chapters also discuss treatment guidelines and case studies.
Unique and focused, Medicinal Cannabis and CBD in Mental Healthcare is an invaluable reference for medical practitioners seeking to adopt CBD-use in their treatment plans.
Preț: 566.04 lei
Preț vechi: 791.83 lei
-29% Nou
Puncte Express: 849
Preț estimativ în valută:
108.34€ • 113.66$ • 89.87£
108.34€ • 113.66$ • 89.87£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030785581
ISBN-10: 3030785580
Pagini: 576
Ilustrații: XXI, 576 p. 1 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.95 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030785580
Pagini: 576
Ilustrații: XXI, 576 p. 1 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.95 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
Introduction.- Endocannabinoid system.- ECS and regulation of stress.- Overview of cannabis.- Stress and Anxiety.-Depression.- PSTD.- Sleep.- Alzheimers.- Autism.- Conclusion.
Notă biografică
Professor Kylie O’Brien PhD
Kylie O’Brien PhDAdjunct Professor Torrens University
Director of Research & Education
International College of Cannabinoid Medicine
Email: kylie@iccm.co
Phone: +61 412 077689
Dr Philip Blair, MD
Dr. Philip Blair, MD, Colonel (US Army Ret)
CEO of AbleDoc, Inc, International Medical Consultant
Chief Medical Officer, International College of Cannabinoid Medicine
Chief Medical Officer, Releaf Clinics, Australia
Chief Science Officer for Harvest 360
CEO of AbleDoc, Inc, International Medical Consultant
Chief Medical Officer, International College of Cannabinoid Medicine
Chief Medical Officer, Releaf Clinics, Australia
Chief Science Officer for Harvest 360
Castle Rock, Washington
email: abledoc@mac.com
Textul de pe ultima copertă
This book functions as a clinician’s guide to the use of cannabidiol (CBD) in the treatment of mental health conditions. It conveys the scientific evidence of efficacy of CBD as well as THC and addresses the social stigma attached to its medical use.
The book describes the endocannabinoid system, how stress and the endocannabinoid system interact and key constituents, pharmacokinetics and safety aspects of medicinal cannabis, focusing on CBD and THC. Chapters on specific mental health conditions describe the underpinning pathomechanisms including how the endocannabinoid system is involved, and summarises the scientific evidence including animal and human research for the use of CBD and THC in treatment of such conditions. Topics covered include anxiety, depression, post-traumatic stress disorder, insomnia, Alzheimer's Disease and autism spectrum disorder. Chapters also discuss treatment guidelines and case studies.
Unique and focused, Medicinal Cannabis and CBD in Mental Healthcare is an invaluable reference for medical practitioners seeking to adopt CBD-use in their treatment plans.
The book describes the endocannabinoid system, how stress and the endocannabinoid system interact and key constituents, pharmacokinetics and safety aspects of medicinal cannabis, focusing on CBD and THC. Chapters on specific mental health conditions describe the underpinning pathomechanisms including how the endocannabinoid system is involved, and summarises the scientific evidence including animal and human research for the use of CBD and THC in treatment of such conditions. Topics covered include anxiety, depression, post-traumatic stress disorder, insomnia, Alzheimer's Disease and autism spectrum disorder. Chapters also discuss treatment guidelines and case studies.
Unique and focused, Medicinal Cannabis and CBD in Mental Healthcare is an invaluable reference for medical practitioners seeking to adopt CBD-use in their treatment plans.
Caracteristici
Unique, focused title on how CBD treatment may be useful in mental health conditions Includes practical algorithms for point of care, clinical use Provides a comprehensive summary of the scientific evidence base for the use of CBD in particular in the treatment of common mental health problems plus guidance on dosing and case studies